Adeno-Associated Virus Vectors in Gene Therapy Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Adeno-Associated Virus Vectors in Gene Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adeno-Associated Virus Vectors in Gene Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adeno-Associated Virus Vectors in Gene Therapy Overall Market Size
2.1 Global Adeno-Associated Virus Vectors in Gene Therapy Market Size: 2021 VS 2028
2.2 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Adeno-Associated Virus Vectors in Gene Therapy Sales: 2017-2028
3 Company Landscape
3.1 Top Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market
3.2 Top Global Adeno-Associated Virus Vectors in Gene Therapy Companies Ranked by Revenue
3.3 Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Companies
3.4 Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Companies
3.5 Global Adeno-Associated Virus Vectors in Gene Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Adeno-Associated Virus Vectors in Gene Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market
3.8.1 List of Global Tier 1 Adeno-Associated Virus Vectors in Gene Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Market Size Markets, 2021 & 2028
4.1.2 Serotype 2 (AVV 2)
4.1.3 Synthetic Serotypes
4.1.4 Others
4.2 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
4.2.1 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2022
4.2.2 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2023-2028
4.2.3 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
4.3 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
4.3.1 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2022
4.3.2 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2023-2028
4.3.3 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
4.4 By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2021 & 2028
5.1.2 Alzheimer's Disease
5.1.3 Cystic Dibrosis
5.1.4 Hemophilia B
5.1.5 Parkinson's Disease
5.2 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
5.2.1 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2022
5.2.2 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2023-2028
5.2.3 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
5.3.1 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2022
5.3.2 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2023-2028
5.3.3 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
5.4 By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2021 & 2028
6.2 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue & Forecasts
6.2.1 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2022
6.2.2 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2023-2028
6.2.3 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales & Forecasts
6.3.1 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2022
6.3.2 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales, 2023-2028
6.3.3 By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2028
6.4.2 By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2028
6.4.3 US Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.4.4 Canada Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.4.5 Mexico Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2028
6.5.2 By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2028
6.5.3 Germany Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5.4 France Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5.5 U.K. Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5.6 Italy Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5.7 Russia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5.8 Nordic Countries Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.5.9 Benelux Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2028
6.6.2 By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2028
6.6.3 China Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.6.4 Japan Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.6.5 South Korea Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.6.6 Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.6.7 India Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2028
6.7.2 By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2028
6.7.3 Brazil Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.7.4 Argentina Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, 2017-2028
6.8.3 Turkey Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.8.4 Israel Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
6.8.6 UAE Adeno-Associated Virus Vectors in Gene Therapy Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Amicus Therapeutics
7.1.1 Amicus Therapeutics Corporate Summary
7.1.2 Amicus Therapeutics Business Overview
7.1.3 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.1.4 Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.1.5 Amicus Therapeutics Key News
7.2 Asklepios Biopharmaceutical
7.2.1 Asklepios Biopharmaceutical Corporate Summary
7.2.2 Asklepios Biopharmaceutical Business Overview
7.2.3 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.2.4 Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Asklepios Biopharmaceutical Key News
7.3 BioMarin Pharmaceutical
7.3.1 BioMarin Pharmaceutical Corporate Summary
7.3.2 BioMarin Pharmaceutical Business Overview
7.3.3 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.3.4 BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.3.5 BioMarin Pharmaceutical Key News
7.4 Coave Therapeutics
7.4.1 Coave Therapeutics Corporate Summary
7.4.2 Coave Therapeutics Business Overview
7.4.3 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.4.4 Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Coave Therapeutics Key News
7.5 MeiraGTx
7.5.1 MeiraGTx Corporate Summary
7.5.2 MeiraGTx Business Overview
7.5.3 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.5.4 MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.5.5 MeiraGTx Key News
7.6 Neurocrine Biosciences
7.6.1 Neurocrine Biosciences Corporate Summary
7.6.2 Neurocrine Biosciences Business Overview
7.6.3 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.6.4 Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Neurocrine Biosciences Key News
7.7 Pfizer
7.7.1 Pfizer Corporate Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.7.4 Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Pfizer Key News
7.8 Roche Holding
7.8.1 Roche Holding Corporate Summary
7.8.2 Roche Holding Business Overview
7.8.3 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.8.4 Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.8.5 Roche Holding Key News
7.9 Sangamo Therapeutics
7.9.1 Sangamo Therapeutics Corporate Summary
7.9.2 Sangamo Therapeutics Business Overview
7.9.3 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.9.4 Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Sangamo Therapeutics Key News
7.10 Sarepta Therapeutics
7.10.1 Sarepta Therapeutics Corporate Summary
7.10.2 Sarepta Therapeutics Business Overview
7.10.3 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.10.4 Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Sarepta Therapeutics Key News
7.11 Spark Therapeutics
7.11.1 Spark Therapeutics Corporate Summary
7.11.2 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.11.3 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.11.4 Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.11.5 Spark Therapeutics Key News
7.12 Voyager Therapeutics
7.12.1 Voyager Therapeutics Corporate Summary
7.12.2 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.12.3 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.12.4 Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.12.5 Voyager Therapeutics Key News
7.13 NightstaRx
7.13.1 NightstaRx Corporate Summary
7.13.2 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Business Overview
7.13.3 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Major Product Offerings
7.13.4 NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales and Revenue in Global (2017-2022)
7.13.5 NightstaRx Key News
8 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity, Analysis
8.1 Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity, 2017-2028
8.2 Adeno-Associated Virus Vectors in Gene Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adeno-Associated Virus Vectors in Gene Therapy Supply Chain Analysis
10.1 Adeno-Associated Virus Vectors in Gene Therapy Industry Value Chain
10.2 Adeno-Associated Virus Vectors in Gene Therapy Upstream Market
10.3 Adeno-Associated Virus Vectors in Gene Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adeno-Associated Virus Vectors in Gene Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer


List of Tables
Table 1. Key Players of Adeno-Associated Virus Vectors in Gene Therapy in Global Market
Table 2. Top Adeno-Associated Virus Vectors in Gene Therapy Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Share by Companies, 2017-2022
Table 5. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Companies, (Kg), 2017-2022
Table 6. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Adeno-Associated Virus Vectors in Gene Therapy Product Type
Table 9. List of Global Tier 1 Adeno-Associated Virus Vectors in Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adeno-Associated Virus Vectors in Gene Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2017-2022
Table 15. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2023-2028
Table 16. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2017-2022
Table 20. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2023-2028
Table 21. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2017-2022
Table 25. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), 2023-2028
Table 26. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2017-2022
Table 29. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2023-2028
Table 30. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2017-2022
Table 33. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2023-2028
Table 34. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2017-2022
Table 37. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2023-2028
Table 38. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2017-2022
Table 41. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales, (Kg), 2023-2028
Table 46. Amicus Therapeutics Corporate Summary
Table 47. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 48. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Asklepios Biopharmaceutical Corporate Summary
Table 50. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 51. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. BioMarin Pharmaceutical Corporate Summary
Table 53. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 54. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. Coave Therapeutics Corporate Summary
Table 56. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 57. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. MeiraGTx Corporate Summary
Table 59. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 60. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Neurocrine Biosciences Corporate Summary
Table 62. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 63. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Pfizer Corporate Summary
Table 65. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 66. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Roche Holding Corporate Summary
Table 68. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 69. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Sangamo Therapeutics Corporate Summary
Table 71. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 72. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Sarepta Therapeutics Corporate Summary
Table 74. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 75. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Spark Therapeutics Corporate Summary
Table 77. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 78. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Voyager Therapeutics Corporate Summary
Table 80. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 81. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. NightstaRx Corporate Summary
Table 83. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product Offerings
Table 84. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Adeno-Associated Virus Vectors in Gene Therapy Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 86. Global Adeno-Associated Virus Vectors in Gene Therapy Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region, 2017-2022 (Kg)
Table 88. Global Adeno-Associated Virus Vectors in Gene Therapy Production by Region, 2023-2028 (Kg)
Table 89. Adeno-Associated Virus Vectors in Gene Therapy Market Opportunities & Trends in Global Market
Table 90. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers in Global Market
Table 91. Adeno-Associated Virus Vectors in Gene Therapy Market Restraints in Global Market
Table 92. Adeno-Associated Virus Vectors in Gene Therapy Raw Materials
Table 93. Adeno-Associated Virus Vectors in Gene Therapy Raw Materials Suppliers in Global Market
Table 94. Typical Adeno-Associated Virus Vectors in Gene Therapy Downstream
Table 95. Adeno-Associated Virus Vectors in Gene Therapy Downstream Clients in Global Market
Table 96. Adeno-Associated Virus Vectors in Gene Therapy Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Adeno-Associated Virus Vectors in Gene Therapy Segment by Type
Figure 2. Adeno-Associated Virus Vectors in Gene Therapy Segment by Application
Figure 3. Global Adeno-Associated Virus Vectors in Gene Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adeno-Associated Virus Vectors in Gene Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. Adeno-Associated Virus Vectors in Gene Therapy Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Adeno-Associated Virus Vectors in Gene Therapy Revenue in 2021
Figure 9. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 10. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 11. By Type - Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 13. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 14. By Application - Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 16. By Region - Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 17. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 18. By Country - North America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 19. US Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 24. Germany Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. France Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 33. China Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. India Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 39. By Country - South America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 40. Brazil Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share, 2017-2028
Figure 44. Turkey Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$, Mn), 2017-2028
Figure 48. Global Adeno-Associated Virus Vectors in Gene Therapy Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Adeno-Associated Virus Vectors in Gene Therapy by Region, 2021 VS 2028
Figure 50. Adeno-Associated Virus Vectors in Gene Therapy Industry Value Chain
Figure 51. Marketing Channels